1. Home
  2. BOLT vs KORE Comparison

BOLT vs KORE Comparison

Compare BOLT & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • KORE
  • Stock Information
  • Founded
  • BOLT 2015
  • KORE 2003
  • Country
  • BOLT United States
  • KORE United States
  • Employees
  • BOLT N/A
  • KORE N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • KORE Telecommunications Equipment
  • Sector
  • BOLT Health Care
  • KORE Consumer Discretionary
  • Exchange
  • BOLT Nasdaq
  • KORE Nasdaq
  • Market Cap
  • BOLT 22.6M
  • KORE 24.7M
  • IPO Year
  • BOLT 2021
  • KORE N/A
  • Fundamental
  • Price
  • BOLT $0.51
  • KORE $2.02
  • Analyst Decision
  • BOLT Hold
  • KORE Buy
  • Analyst Count
  • BOLT 5
  • KORE 2
  • Target Price
  • BOLT $1.25
  • KORE $10.00
  • AVG Volume (30 Days)
  • BOLT 186.2K
  • KORE 579.9K
  • Earning Date
  • BOLT 11-12-2024
  • KORE 11-19-2024
  • Dividend Yield
  • BOLT N/A
  • KORE N/A
  • EPS Growth
  • BOLT N/A
  • KORE N/A
  • EPS
  • BOLT N/A
  • KORE N/A
  • Revenue
  • BOLT $9,779,000.00
  • KORE $285,229,000.00
  • Revenue This Year
  • BOLT $9.87
  • KORE $3.89
  • Revenue Next Year
  • BOLT N/A
  • KORE $5.35
  • P/E Ratio
  • BOLT N/A
  • KORE N/A
  • Revenue Growth
  • BOLT 35.86
  • KORE 7.01
  • 52 Week Low
  • BOLT $0.48
  • KORE $1.10
  • 52 Week High
  • BOLT $1.56
  • KORE $5.45
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 41.39
  • KORE 51.10
  • Support Level
  • BOLT $0.50
  • KORE $1.77
  • Resistance Level
  • BOLT $0.55
  • KORE $4.88
  • Average True Range (ATR)
  • BOLT 0.04
  • KORE 0.52
  • MACD
  • BOLT -0.00
  • KORE -0.04
  • Stochastic Oscillator
  • BOLT 13.04
  • KORE 11.18

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates a majority of its revenue from the United States and the rest from other countries.

Share on Social Networks: